Interleukin-1 receptor-associated kinase-like 2 (IRAK2)

The protein contains 625 amino acids for an estimated molecular weight of 69433 Da.

 

Binds to the IL-1 type I receptor following IL-1 engagement, triggering intracellular signaling cascades leading to transcriptional up-regulation and mRNA stabilization. (updated: Sept. 12, 2018)

Protein identification was indicated in the following studies:

  1. Bryk and co-workers. (2017) Quantitative Analysis of Human Red Blood Cell Proteome. J Proteome Res. 16(8), 2752-2761.

Methods

The following articles were analysed to gather the proteome content of erythrocytes.

The gene or protein list provided in the studies were processed using the ID mapping API of Uniprot in September 2018. The number of proteins identified and mapped without ambiguity in these studies is indicated below.
Only Swiss-Prot entries (reviewed) were considered for protein evidence assignation.

PublicationIdentification 1Uniprot mapping 2Not mapped /
Obsolete
TrEMBLSwiss-Prot
Goodman (2013)2289 (gene list)227853205992269
Lange (2014)123412347281224
Hegedus (2015)2638262202352387
Wilson (2016)165815281702911068
d'Alessandro (2017)18261817201815
Bryk (2017)20902060101081942
Chu (2018)18531804553621387

1 as available in the article and/or in supplementary material
2 uniprot mapping returns all protein isoforms as one entry

The compilation of older studies can be retrieved from the Red Blood Cell Collection database.

The data and differentiation stages presented below come from the proteomic study and analysis performed by our partners of the GReX consortium, more details are available in their published work.

No sequence conservation computed yet.

This protein is annotated as membranous in Gene Ontology.


Interpro domains
Total structural coverage: 0%
Model score: 38

(right-click above to access to more options from the contextual menu)

VariantDescription
dbSNP:rs34945585
dbSNP:rs11465864
dbSNP:rs55898544
dbSNP:rs56053222
dbSNP:rs35060588
a lung adenocarcinoma sample; somatic mutation
dbSNP:rs3844283
a lung adenocarcinoma sample; somatic mutation
dbSNP:rs708035
dbSNP:rs11465927
dbSNP:rs56242986
dbSNP:rs9854688
dbSNP:rs55740652
dbSNP:rs11465930

No binding partner found

The reference OMIM entry for this protein is 603304

Interleukin 1 receptor-associated kinase 2; irak2

CLONING

The interleukin-1 receptor (IL1R) signaling pathway leads to nuclear factor kappa-B (NFKB; e.g., 164011) activation in mammals. After binding to IL1 (e.g., 147760), the type 1 IL1R (IL1R1; 147810) associates with the IL1R accessory protein (IL1RAP; 602626) and initiates the signaling cascade. Multiple protein kinase activities coprecipitate with IL1R1, including IRAK1 (300283). By searching EST databases for sequences similar to IRAK1, Muzio et al. (1997) identified IRAK2. The deduced protein contains 590 amino acids. Northern blot analysis detected an approximately 4-kb IRAK2 transcript in a variety of adult human tissues.

BIOCHEMICAL FEATURES

- Crystal Structure Lin et al. (2010) reported the crystal structure of the MyD88 (602170)-IRAK4 (606883)-IRAK2 death domain complex, which revealed a left-handed helical oligomer that consists of 6 MyD88, 4 IRAK4, and 4 IRAK2 death domains. Assembly of this helical signaling tower is hierarchical, in which MyD88 recruits IRAK4 and the MyD88-IRAK4 complex recruits the IRAK4 substrates IRAK2 or the related IRAK1. Formation of these myddosome complexes brings the kinase domains of IRAKs into proximity for phosphorylation and activation. Composite binding sites are required for recruitment of the individual death domains in the complex, which are confirmed by mutagenesis and previously identified signaling mutations. Specificities of myddosome formation are dictated by both molecular complementation and correspondence of surface electrostatics.

GENE FUNCTION

Muzio et al. (1997) showed that ectopic expression of IRAK2 protein induced NFKB activation, whereas expression of truncated IRAK2 proteins did not. Truncated forms of IRAK2 acted as dominant-negative inhibitors of IL1R-induced NFKB activity. IRAK2 coprecipitated with MYD88 (602170) and TRAF6 (602355), another protein implicated in the IL1 signaling pathway and shown to complex with IRAK1. Muzio et al. (1997) concluded that IRAK2 is a proximal mediator of IL1, is a component of the IL1R signaling complex, and is required for IL1R-induced NFKB activation.

ANIMAL MODEL

Conner et al. (2009) detected an earlier, more potent Toll-like receptor (TLR; see 603030)-mediated induction of Il6 (147620) transcription in a wild-derived mouse strain, MOLF/Ei, compared with the classical inbred strain C57BL/6J. The phenotype correlated with increased activity of the I-kappa-B kinase (see 600664) axis and p38 (MAPK14; 600289), but not Mapk1 (176948), Mapk3 (601795), or Mapk8 (601158). The trait was mapped to the Why1 locus, which contains Irak2, on mouse chromosome 6. Conner et al. (2009) showed that, in the MOLF/Ei TLR signaling network, Irak2 promoted early NF-kappa-B activity and was essential for p38 activation. In the MOLF/Ei strain, they identified a 10-bp deletion in the promoter region of an inhibitory Irak2 variant, Irak2c, leading to an increased ratio of pro- to antiinflammatory Irak2 isoforms. Conner et al. (2009) concluded that Irak2 is an essential component of the early TLR response in wild-derived MOLF/Ei mice and that the pathway of p38 and NF-kappa-B activation is distinct in this organism. ... More on the omim web site

Subscribe to this protein entry history

June 30, 2020: Protein entry updated
Automatic update: OMIM entry 603304 was added.

Dec. 10, 2018: Protein entry updated
Automatic update: model status changed

Oct. 19, 2018: Additional information
Initial protein addition to the database. This entry was referenced in Bryk and co-workers. (2017).